Keep a symptom journal to track meals, medication timing, and reactions
Sources Unleashing the power of retatrutide: A possible triumph over obesity and overweight: A correspondence PMC TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial New England Journal of Medicine Lillys phase 2 retatrutide results published in The New England Journal of Medicine show the investigational molecule achieved up to 17.5% mean weight reduction at 24 weeks in adults with obesity and overweight Eli Lilly and Company NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current
Are you pregnant
IV therapies can be a powerful tool in addressing common pregnancy concerns like hyperemesis gravidarum, nutrient deficiencies, and chronic dehydration
Mounjaro side effects hair loss Although Mounjaro (also known as trizepatide) does not directly result in hair loss on its own, a swift decrease in weight due to the medication may occasionally induce an issue known as telogen effluvium, which can cause an increase in hair shedding
This helps you understand your progress and keeps you motivated to maintain lifestyle changes